Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Last-resort cancer therapy holds back disease for more than a decade

Two of the first people treated with CAR-T-cell cancer therapies are still in remission 12 years on.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

A few weeks after receiving an experimental cancer therapy that turns immune cells into tumour-killing hunters, Doug Olson’s doctor sat him down to give him news of his progress. “He said, ‘Doug, we cannot find a single cancer cell in your body,’” Olson recalls. “I was pretty convinced that I was done with cancer.”

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 602, 196 (2022)

doi: https://doi.org/10.1038/d41586-022-00241-0

References

  1. Melenhorst, J. J. et al. Nature https://doi.org/10.1038/s41586-021-04390-6 (2022).

    Article  Google Scholar 

  2. Rurik, J. G. et al. Science 375, 91–96 (2022).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links